Abstract
Amoeboid microglial cells (AMCs) in the developing brain display surface receptors and antigens shared by the monocyte-derived tissue macrophages. Activation of AMCs in the perinatal brain has been associated with periventricular white matter damage in hypoxic-ischemic conditions. The periventricular white matter, where the AMCs preponderate, is selectively vulnerable to hypoxia as manifested by death of premyelinating oligodendrocytes and degeneration of axons leading to neonatal mortality and long-term neurodevelopmental deficits. AMCs respond vigorously to hypoxia by producing excess amounts of inflammatory cytokines e.g. the tumor necrosis factor–α (TNF-α) and interleukin-1β (IL-1β) along with glutamate, nitric oxide (NO) and reactive oxygen species which collectively cause oligodendrocyte death, axonal degeneration as well as disruption of the immature blood brain barrier. A similar phenomenon is observed in the hypoxic developing cerebellum in which activated AMCs induced Purkinje neuronal death through production of TNF-α and IL-1β via their respective receptors. Hypoxia is also implicated in retinopathy of prematurity in which activation of AMCs has been shown to cause retinal ganglion cell death through production of TNF-α and IL-1β and NO. Because AMCs play a pivotal role in hypoxic injuries in the developing brain affecting both neurons and oligodendrocytes, a fuller understanding of the underlying molecular mechanisms of microglial activation under such conditions would be desirable for designing of a novel therapeutic strategy for management of hypoxic damage.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The brain consists of the neurons and three major types of glial cells, namely the astrocytes, oligodendrocytes and microglia. In the latter, the first description dates back to the late 19th century when Nissl (1899) described them as “the rod cells”. Following this, Cajal (1913) referred to them as the ‘third element’ other than the neurons and neuroglia. del Rio-Hortega (1932) had identified the glial type with the weak silver carbonate staining, considered then to be a reliable staining method for microglia. The identification and characterization of microglia was established later by electron microscopy, histochemical and immunohistochemical staining. Microglial cells are ubiquitous in the central nervous system (CNS). In the mature brain, they are characterized by a small flattened cell body giving rise to a variable number of branching processes or ramifications. The occurrence of the nascent form of microglia is well documented in the developing brain (Ling and Wong 1993). Termed the amoeboid microglial cells (AMCs), the cells have a rounded cell body which emits filopodial and pseudopodial processes.
AMCs are distributed preferentially in large numbers in the developing white matter tracts notably in the supraventricular region of the corpus callosum, also called the periventricular white matter (PWM). The PWM in the early postnatal brain consists of unmyelinated nerve fibres and glial cells including the astrocytes, oligodendrocytes, glioblasts and AMCs. It is well documented that the developing brain is highly susceptible to hypoxic damage, the PWM being selectively vulnerable to hypoxic-ischemic damage in premature infants (Johnston 1997; McQuillen and Ferriero 2004 ; Volpe 2003; Follett et al. 2004; Folkerth 2006). Hallmark features of PWM damage are death of immature oligodendrocytes before the onset of myelination and axonal degeneration (Dammann et al. 2001; Ness et al. 2001). Although several factors such as increased release of glutamate, oxidative and nitrosative stress and inflammation have been implicated in the pathogenesis of PWM damage, the contributory role of AMCs to the damage have remained elusive until recently.
Amoeboid microglial cells
Distribution
Although ubiquitously distributed in the brain, the AMCs are mostly located in the developing white matter tracts forming a conspicuous colony in the PWM (Fig. 1a); other areas near the PWM where the AMCs preponderate include the cavum septum pellucidum and the subventricular zone (Fig. 1b). The cells exist either singly or in clusters and may be closely associated with the blood vessels (Fig. 1c). A majority of the AMCs have a rounded cell outline bearing a few stout cytoplasmic processes. At the ultrastructural level, the abundant cytoplasm shows dense granules of various sizes, scattered mitochondria, stringy cisternae of rough endoplasmic and a well-developed Golgi complex (Fig. 2a). Some membrane bound vacuoles and a few lipid droplets are mainly confined to the periphery of the cytoplasm. The round or oval nucleus showing condensed chromatin masses is usually placed eccentrically. By scanning electron microscopy, the cell surface exhibits blebs and filopodial projections (Fig. 2b).
Tracer studies have shown that the AMCs transform into ramified microglia with advancing age assuming an oval cell body with concomitant reduction in cytoplasm (Leong and Ling 1992; Wu et al. 1994). In the course of microglial development, some of the AMCs undergo apoptosis and appear to be engulfed by their companion AMCs; others emigrate to other areas (Ling and Tan 1974; Imamoto and Leblond 1978). The mechanism guiding this ‘self-elimination process’ of the microglial cell population has remained obscure.
Monocytic and macrophagic nature of AMCs
The description of source of microglial precursors had been a debated issue and focus of many investigators in the past few decades. In animals such as rodents and in humans two different pools of myeloid cells are thought to be the precursors of microglia—progenitors invading the early embryonic brain from the yolk sac (Alliot et al. 1999; Cuadros et al. 1993), and monocytes invading the brain during late embryonic or early postnatal period (Ling and Tan 1974; Imamoto and Leblond 1978; Ling et al. 1982; Kaur et al. 1984). Using lectin labeling we have shown that the first colonization of macrophages in the fetal mouse brain was independent of its vascularization and that the cells appear to originate from some lectin-labeled precursor cells in the yolk sac (Kaur et al. 2001). Several studies carried out in our laboratory using histochememical and immunohistochemical techniques have demonstrated the entry of monocytes into the developing brain to become AMCs (Ling et al. 1980, 1982; Kaur et al. 1984; Ling et al. 1990). The finding that microglial cells express receptors for colony stimulating factors (CSFs), a group of cytokines known to regulate cells of monocytic lineage, and that CSF-1 induces proliferation and morphological changes in microglia provides support to the monocytic nature of microglia (Sawada et al. 1990; Suzumura et al. 1990; Shafit-Zagardo et al. 1993). As in monocytes, CSF-1 has been reported to increase the lysosomal activity in microglia, indicating the similarity of microglia to the mature cells of monocytic lineage (Suzumura et al. 1990). Additionally, we have shown that AMCs are labeled by ED1, a cellular marker for monocytes/macrophages (Kaur and Ling 1995, 1999). It needs to be pointed out that the early proposal of the monocytic and macrophagic nature of AMCs (Ling and Wong 1993) is fundamental to the understanding of the roles of these cells both in physiological and pathological conditions as described below.
Functions of AMCs
Phagocytosis and antigen presentation
The ability of AMCs to phagocytose degenerating axons and cells is evident during normal brain development (Kaur et al. 1985) as well as in experimental/pathological conditions where they have been found to be engaged in removal of apoptotic or necrotic cells (Kaur et al. 2006a). The macrophagic nature of AMCs is further established by the fact that they possess a repertoire of hydrolytic enzymes such as acid phosphatase, aryl sulphatase, non-specific esterase and 5′- nucleotidase (Ling 1977; Ling et al. 1982; Kaur et al. 1984) that are also present in macrophages at other sites in the body. Internalization of intraperitoneally or intravenously administered exogenous agents such as rhodamine isothiocyanate and horseradish peroxidase or E coli reaching the immature brain through the vascular route by AMCs (Kaur et al. 1986, 2004; Xu et al. 1993) further strengthens the notion that they are active phagocytes. Expression of complement type 3 receptors (CR3) on the AMCs, known to be involved in endocytosis (Ling et al. 1990) further corroborates the macrophagic lineage of these cells as CR3 are also expressed on other tissue macrophages (Newman et al. 1980; Beller et al. 1982; Abrahamson and Fearon 1983) and are known to be involved in endocytosis (Ling et al. 1990)
Expression of major histocompatibility (MHC) class I antigens (Ling et al. 1991) under normal conditions and MHC class II under pathological and experimental conditions (Xu and Ling 1994a) ascertains the possibility that the cells could present antigens to lymphocytes in the event of an infection or lymphocytes entering the brain through a breach in the vascular walls. In vitro studies have shown that in response to inflammation, activated microglia up regulate the expression of CD45 along with co-stimulatory molecules such as CD40, CD80, CD86 which are essential for antigen presentation and T cell activation (Aloisi et al. 1998). Activation of intracerebrally recruited T cells depends on the ability of MHC class II positive microglia to endocytose and present antigens to the T cells (Aloisi 2001). For example, in human fetal microglial cultures, following toll like receptor 3 induced activation, microglia expressing MHC class II were reported to activate CD4+ T cell response (Jack et al. 2007). Several in vivo and in vitro studies have shown the antigen presenting function of microglia through the acquisition of macrophagic properties (see review by Aloisi 2001).
Other functions
Besides phagocytosis, AMCs also partake in certain development events such as promotion of oligodendrocyte proliferation through secretion of insulin-like growth factor-1 (IGF-1) that is required for the proper development of the neural tissues. IGF-1 is known to foster proliferation of oligodendrocytes as well as their myelin synthesis in the developing brain (Dubois-Dalcq and Murray 2000; Guan et al. 2001). Expression of IGF-I and IGF-2 on the AMCs has been reported (Kaur et al. 2006b) and it was suggested that this may also be involved in enhancing the phagocytic activity as has been reported in the peritoneal macrophages (Inoue et al. 1995). IGF-2 may play a role in myelination (Logan et al. 1994; Walter et al. 1999) or in the phagocytic activity of AMCs (Kaur et al. 2006b).
We have recently reported that transforming growth factor (TGF)-βl, a prototype of multifunctional growth factors generally considered as an anti-inflammatory cytokine, and its receptors TβRI and TβRII are expressed constitutively by the AMCs in the PWM of neonatal rats. The expression of TGF-β1 and its receptors in the AMCs was markedly upregulated after a hypoxic exposure suggesting that it may help to autoregulate microglial activation in adverse conditions via its receptors (Li et al. 2008).
The varied functions of microglia came to light from the recent studies which demonstrated the involvement of microglia in vasculogenesis, synaptic pruning, neurogenesis and astrogenesis. Microglia which invade the retina and brain prior to vascularisation are found in association with the tip cells of growing vascular plexus (Fantin et al. 2010; Rymo et al. 2011) and have an intimate association with vascular endothelium and vascular sprouts (Provis et al. 1997). The depletion of microglia in two mutant mouse models: macrophage colony-stimulating factor (M-CSF)/CSF-1 deficient mice and PU.1 null mice, resulted in sparser vascular complexity implicating the essential role of microglia in vasculogenesis (Kubota et al. 2009; Fantin et al. 2010). In addition it has been suggested that the association of AMCs with the microvessels in the postnatal PWM may have a role in maintaining the function of the blood- brain barrier by ingesting any serum- derived foreign substances (Xu and Ling 1994b; Kaur et al. 1986).
The role of microglia in synaptic elimination during postnatal synaptic remodelling has gained importance in recent years. Immunohistochemical studies in the past have revealed the presence of microglia bearing many processes in the brain (Perry et al. 1985; Fiske and Brunjes 2000) which are now known to interact with the synapses. The frequent and transient contacts established by microglial processes with the synapses suggest that microglia could have a role in monitoring and in remodelling the synapses (Wake et al. 2009; Tremblay et al. 2010). As synapses are endowed with complement component C3, the recognition of these components by microglial complement receptors was implicated in synaptic elimination (Schafer et al. 2010). In mice lacking Cx3cr1, a chemokine fractalkine receptor expressed by microglia, there was a delay in synaptic pruning due to the impairment in migration of microglia towards the neurons expressing chemokine fractalkine, Cx3cl1(Paolicelli et al. 2011).
Though microglia phagocytose supernumerary neurons and synapses as a process of development they also have a role in defining the neural precursor environment. The presence of microglia in the neural precursor regions has been implicated in the regulation of precursor proliferation and astrogenesis (Antony et al. 2011). Several in vitro studies have demonstrated the role of microglia in causing differentiation of neural precursor cells to neuronal phenotype (Aarum et al. 2003), basal progenitor cells to cholinergic neruons (Jonakait et al. 1996, 2000) and in directing the migration of neural precursors (Aarum et al. 2003). Also, astrogenesis was found to be reduced in PU.1-/- mice, owing to a reduction in microglia numbers (Antony et al. 2011) and this was attributed to the reduced availability of microglial secretory factors such as leukemia inhibitory factor (Zhu et al. 2008). Besides the above, it was suggested that the AMCs in the PWM could have a role in axon growth and guidance during development (Streit 2001).
Activation of AMCs in pathological states
In pathological conditions or injuries of the mature brain, the microglia transform into “activated microglia” or “reactive microglia” when they retract their processes and their cell bodies become larger. However, in the developing PWM, activation of AMCs following an injury does not necessarily involve a change in its shape but is manifested by alteration in the expression of surface receptors and antigens. For example, the expression of CR3 and MHC I antigens was drastically enhanced along with induction of MHC II antigens when the cells were challenged with lipopolysaccaride (Xu and Ling 1994a) or E coli (Kaur et al. 2004) suggesting that the phagocytic activity and antigen presentation capability of the AMCs was increased. Furthermore, they were involved actively in removing apoptotic/necrotic cells and degenerating axons in the PWM following a hypoxic injury (Kaur et al. 2006a). The expression level of proinflammatory molecules notably tumor necrosis factor (TNF)-α and interleukin (IL)-1β by the AMCs following hypoxic-ischemic injuries is markedly enhanced when compared to that under normal conditions (Fig. 3) suggesting the involvement of AMCs in an inflammatory reaction (Deng et al. 2008). Activated AMCs are known to proliferate and migrate to the site of injury so that their numbers are increased significantly (Deng et al. 2009). Other than the cytokines, activated AMCs are known to produce nitric oxide (NO) through inducible nitric oxide synthase (iNOS) which may be detrimental to the oligodendrocytes (Merrill et al. 1993; Kaur et al. 2006a). Activated AMCs can also generate reactive oxygen species (ROS) when stimulated by hypoxia (Kaur and Ling 2009). As AMCs are prevalent in the PWM, it is conceivable that excess production of a plethora of neurotoxic factors would inundate the tissue and affect the ambient cellular constituents such as oligodendrocytes, axons etc.
Hypoxia induced periventricular white matter damage in the developing brain
Neuropathology
Hypoxia-ischemia is a leading cause of morbidity and mortality in the perinatal period (Calvert and Zhang 2005). The developing brain is highly vulnerable to oxygen deprivation or hypoxia which affects its normal development and maturation (Perlman 2006). Placental insufficiency, decreased utero-placental blood flow and premature onset of labor or prolonged labor are risk factors which may compromise fetal oxygenation. Neonatal hypoxia results from pulmonary and/or cardiac dysfunction or neonatal stroke (Jiang et al. 2003). The PWM is selectively vulnerable to damage in premature infants (McQuillen and Ferriero 2004 ; Folkerth 2006).
Swollen or degenerating axons, activated microglia, astrocytosis and oligodendroglial death have been reported as the main pathological features of hypoxic-ischemic damage in the PWM in various animal models (Takashima et al. 1995; Skoff et al. 2001; Ness et al. 2001; Kaur et al. 2006a). AMCs engaged in phagocytosis of the degenerating axons and necrotic/apoptotic cells is a hallmark feature of periventricular white matter damage (PWMD) (Kaur and Ling 2009). Delayed myelination as evidenced by significantly decreased myelin basic protein (MBP) (Kaur et al. 2006a) and cystic cavities are known to occur in late stages of the PWMD. These changes may be accompanied by the presence of edema in the PWM, hemorrhages, dilatation of the lateral ventricles and structural alterations in the ependymal lining and the choroid plexus epithelial cells.
Pathogenesis
The factors underlying hypoxia-ischemia induced white matter damage have been the focus of several investigations in recent years. Both in vivo and in vitro methods have been adopted to elucidate the pathogenic mechanisms leading to oligodendrocyte death and axon damage. Increased release of glutamate, free radical generation and inflammation in the PWM in response to hypoxia are culpably involved in the pathogenesis of white matter damage. These are discussed below with special reference to the involvement of AMCs in causing damage through production of inflammatory cytokines and free radicals. Along with this, our recent findings have further extended the role of glutamate induced cell death and increased iron accumulation in causing PWMD through the AMCs.
Role of AMCs in glutamate induced cell death
In hypoxic-ischemic injuries, increased accumulation of extracellular glutamate in the white matter may occur possibly due to release from damaged axons and glia (Meng et al. 1997; Fern and Møller 2000). Glutamate increase in neural tissues results in overactivation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and N-methyl-D-aspartate (NMDA) receptors which are considered as major players in mediating injury to oligodendrocytes in hypoxic-ischemic conditions (Yoshioka et al. 1995; McDonald et al. 1998; Deng et al. 2003; Salter and Fern 2005; Matute et al. 2007). We have reported recently that glutamate concentration in the PWM of neonatal rats was increased following a hypoxic injury (Sivakumar et al. 2010). AMCs were shown to release increased levels of glutamate following the hypoxic injury. Concomitantly, the expression of AMPA glutamate receptors (GluR2-4) and NMDA receptor subunits (NR1, NR2A-D) was increased on the AMCs (Kaur et al. 2006a; Sivakumar et al. 2010; Murugan et al. 2011). Overactivation of glial AMPA receptors has been described to play an important role in disruption of axons (Tekkok and Goldberg 2001) and oligodendrocyte damage (Fern and Møller 2000; Fontaine et al. 2002).
Expression of NMDAR receptors on AMCs was proposed to cause damage to oligodendrocytes through activation of NF-ĸB pathway. Glutamate induced NMDA receptor activation in AMCs was found to induce iNOS expression via the NF-ĸB signalling pathway in neonatal rats following a hypoxic exposure (Murugan et al. 2011). A decrease in hypoxia induced NMDAR-mediated iNOS expression by microglia was observed when the cells were incubated with BAY, a selective inhibitor of NF-ĸB 30 min prior to hypoxia treatment (Murugan et al. 2011). Expression of iNOS in the AMCs is known to result in tissue damage through production of NO. In vitro studies have shown that NO produced by AMCs is highly damaging to the oligodendrocytes by causing their lysis (Merrill et al. 1993). Enhanced death of oligodendrocytes has been reported when primary oligodendrocytes were treated with conditioned medium from microglia cultures exposed to hypoxia; the cell death was reduced with NMDA receptor antagonist MK801, BAY and iNOS inhibitor1400w. In the light of these results, it was suggested that activation of NMDARs on the AMCs by glutamate following hypoxia might be involved in iNOS synthesis via activation of NF-ĸB leading to death of oligodendrocytes (Murugan et al. 2011). These observations are supported by previous studies which have shown that hypoxia induced the expression of iNOS on the AMCs in the PWM of hypoxic neonatal rats (You and Kaur 2000; Kaur et al. 2006a).
Besides the excitotoxic effects, increased release of glutamate may also be involved in enhancing the release of proinflammatory cytokines TNF-α and IL-1β by the AMCs. Primary cultures of AMCs subjected to glutamate showed significantly higher release of these cytokines when compared to the controls (Sivakumar et al. 2010) suggesting that increased release of glutamate under hypoxic states may activate the AMCs to produce higher amounts of cytokines. In addition to this, the AMCs may also contribute to accumulation of excess glutamate in the extracellular spaces in the hypoxic PWM as our in vitro experiments showed that the primary microglia subjected to hypoxia release higher amounts of glutamate (Sivakumar et al. 2010).
Very interestingly, glutamate was also found to suppress the release of IGF-I and IGF-II by the AMCs (Sivakumar et al. 2010). IGF-I plays a significant role in recovery from insults such as hypoxia-ischemia (Guan et al. 2003). Glutamate induced reduction in release of these growth factors by the AMCs may cause injury to the oligodendrocytes and axons due to excitotoxicity and enhanced production of inflammatory cytokines. This is especially so in view of our findings that primary microglial cells transfected with IGF-I siRNA showed a signifant increase in glutamate, TNF-α, and IL-1β production (Sivakumar et al. 2010).
Role of AMCs in inflammation
The involvement of inflammation in causing PWMD in hypoxic-ischemic conditions is well recognized (Kadhim et al. 2002). Hypoxia is an important stimulus for production of inflammatory chemokines and cytokines (Carloni et al. 2006; Guo and Bhat 2006). We have shown that activated AMCs express enhanced levels of TNF-α and IL-1β in response to hypoxia (Fig. 3) (Deng et al. 2008). In response to hypoxia, AMCs also produce other molecules such as syndecan-2, one of the major heparan sulfate glycosaminoglycan-containing cell surface proteins, and exhibit enhanced expression of ion channels such as Kv1.1 and Kv1.2 (Li et al. 2008; Kaur et al. 2009a; Wu et al. 2009) that have been reported to promote the release of inflammatory cytokines and chemokines (Li et al. 2008; Kaur et al. 2009a, b; Wu et al. 2009).
TNF-α acts through its receptor 1 (TNF-R1) or 2 (TNF-R2). Activation of TNF-R1 elicits caspase signal pathways that lead to cell apoptosis (Nakazawa et al. 2006). TNF-R2 is known to activate Akt signaling pathway to promote cell growth and proliferation (Fontaine et al. 2002). Expression of TNF-R1 on the oligodendrocytes in the PWM was found to be increased after a hypoxic exposure in neonatal rats suggesting that TNF-α may induce apoptosis of oligodendrocytes via binding to TNF-R1 (Deng et al. 2008). The unmyelinated axons also showed an upregulated expression of TNF-R1 coupled with the disruption of MBP immunopositive processes of oligodendrocytes in the PWM of hypoxic neonatal rats suggesting that overproduction of TNF-α may damage axons and delay their myelination via binding to their respective receptors (Deng et al. 2010).
IL-1β acts through binding to type I and type II IL-1R. The expression of IL-1R1 on the oligodendrocytes in PWM in hypoxic rats was found to be increased significantly (Deng et al. 2008). Although IL-1β was reported as being non toxic to oligodendrocyte lineage cells as oligodendrocyte apoptosis was not induced through this receptor, it can block oligodendrocyte proliferation at the late progenitor/pro-oligodendrocyte stage (Vela et al. 2002) suggesting that white matter development and recovery in hypoxic conditions via inhibition of oligodendrocyte progenitor proliferation by IL-1 β may be delayed. In addition to these observations, IL-1β and TNF-α may also be involved in the activation of iNOS gene (Lopez-Figueroa et al. 2000; Kadhim et al. 2006) and hence generation of NO. In support of these observations, AMCs were found to express iNOS in response to hypoxia (Kaur et al. 2006a).
AMCs may also be involved in exacerbation of the inflammatory response through secretion of monocyte chemoattractant protein-1 (MCP-1) and macrophage-colony stimulating factor (M-CSF). MCP-1 is a chemokine which modulates migration of activated microglial cells and leukocytes to the inflammatory sites in the CNS (Lu et al. 1998; Rankine et al. 2006; Yan et al. 2007) through binding with its G protein-coupled receptor CCR2. It was reported that the primary source of MCP-1 in the neonatal brain was the AMCs (Deng et al. 2009). MCP-1, its receptor CCR2 and the numbers of AMCs increased in the PWM in response to hypoxia. This was attributed primarily to the migration of AMCs from the neighboring areas of the brain or from invasion of the monocytes into the hypoxic brain (Deng et al. 2009).
M-CSF, also known as colony stimulating factor (CSF)-1, is a cytokine released mainly by macrophages, T cells, B cells, microglia (Lee et al. 1993) and astrocytes (Hao et al. 1990; Lee et al.1993) and is an important mediator of inflammation (Hao et al. 2002; Deng et al. 2010). M-CSF exerts its actions by binding to its receptor CSF-1R and is known to have a role in microglial inflammatory response (Murphy et al. 2000). Following brain injury or in diseases such as Alzheimer’s disease, up-regulation of M-CSF in activated microglia is accompanied by CSF-1R expression (Murphy et al. 2000; Takeuchi et al. 2001). The overexpression of M-CSF receptors on the microglia is suggested to exacerbate the inflammatory process by propagating the proinflammatory signals to the nearby resting microglia and astrocytes through increased production of proinflamamtory cytokines (Hao et al. 2002). Our recent study showed enhanced expression of M-CSF by AMCs in the PWM in response to hypoxia and, concurrently the astrocytes expressed amplified CSF-1R, TNF-α and IL-1β (Deng et al. 2010). It was suggested that the interaction between AMCs and astrocytes via the M-CSF and its receptor led to release of proinflammatory cytokines such as TNF-α and IL-1β from the astrocytes augmenting the inflammatory response in the PWM of the hypoxic neonatal rats.
Though CSF-1R was suggested to be a definitive marker of cells of mononuclear phagocyte lineage which includes microglia (Sasmono et al. 2003) previous studies have demonstrated the proximal c-fms promoter activity in the astrocytes (Tkachuk and Gisler 1997) and expression of the mRNAs of receptors for M-CSF and GM-CSF in astrocytes (Sawada et al. 1993). The discrepancy might be due to the description of the c-fms promoter region in different studies. Additionally the presence of GM-CSF receptors on the cell membrane of the cultured simian astrocytes was demonstated by Guillemin et al. (1996) using immunofluorescence technique.
Role of AMCs in oxidative stress
Under normal conditions, the generation of reactive oxygen species (ROS) in the tissues of the body is balanced as the endogenous antioxidants either neutralize or eliminate them. Oxidative stress occurs when the balance between the formation of ROS and the ability of cells to defend against them is disrupted. ROS is a product of the multi subunit phagocyte NADPH oxidase comprising of P22 phox, P47 phox, P67 phox and gp91 phox (Bedard and Krause 2007). The abundant amount of ROS produced by the activated microglial cells is through the induction of phagocyte NADPH oxidase (Lavigne et al. 2001; Huo et al. 2011). ROS produced by microglia causes detrimental effects to the neurons and oligodendrocytes and has been implicated in causing damage to myelin sheath (van der Goes et al. 1998). Release of ROS by AMCs in the PWM is increased significantly following hypoxic injury (Kaur et al. 2009a; Rathnasamy et al. 2011). Immature oligodendrocytes in the PWM are highly susceptible to damage from oxidative stress (Haynes et al. 2005) and their selective degeneration is the result of lipid peroxidation caused by ROS (Griot et al. 1990). Activated microglia are also known to release reactive nitrogen species (RNS) (Murphy et al. 1993; Hanisch 2002; Nakanishi 2003) which plays a crucial role in the pathogenesis of developing white matter lesions (Haynes et al. 2005). Expression of iNOS and RNS is known to be triggered by hypoxia in AMCs in the PWM of neonatal animals (You and Kaur 2000; Murugan et al. 2011; Rathnasamy et al. 2011). It has been reported that excessive production of NO from iNOS is toxic to the oligodendrocytes (Merrill et al. 1993). The synergistic activation of NADPH oxidase and iNOS could lead to peroxynitrite formation, a potent oxidising agent (Brown 2007).
We have already shown that hypoxia elicited an increase in iron levels in the PWM with specific localization of iron in AMCs along with increased expression of iron regulatory proteins and transferrin receptors (Kaur and Ling 1999; Rathnasamy et al. 2011). Intracellular iron increase in AMCs was accompanied by increase in ROS, TNF-α and IL-1β generation and increased oligodendrocyte apoptosis; these biomarkers were reduced on treatment with the iron chelator deferoxamine. Based on these results, it was suggested that increased intracellular iron in AMCs is a major contributing factor to the enhanced release of ROS and cytokines that cause apoptosis of oligodendrocytes by reducing their antioxidant defenses as manifested by the reduced glutathione and increased lipid peroxidation in hypoxic injury (Rathnasamy et al. 2011).
Hypoxia induced damage in the developing cerebellum
Motor functions such as co-ordination, posture and equilibrium are controlled by the cerebellum. Cerebellar damage results in ataxia or an incoordination of movements (Gilman 1992) due to loss of Purkinje neurons which have been described to be exceptionally vulnerable to hypoxic and ischemic insult (Barenberg et al. 2001). In addition, cerebellar injury in preterm infants or in the neonatal period has been suggested to result in cognitive-behavioral dysfunction (Limperopoulos and du Plessis 2006). Several risk factors similar to those mentioned above for the PWM and the developing retina such as abnormal placental insufficiency and early postnatal cardiorespiratory instability resulting in fetal hypoxemia affect the development and growth of the cerebellum (Mallard et al. 1998). Hypoxia causes apoptosis of the Purkinje neurons and a significant decrease in the thickness of molecular and granular layers in the developing cerebellum (Biran et al. 2011; Sivakumar et al., unpublished data). Although the mechanisms responsible for the death of Purkinje neurons in hypoxic injuries in the perinatal period are not known, our recent results suggest that hypoxia induced increased production of TNF-α and IL-1β by the AMCs, which are present in large numbers in the cerebellar white matter as well as in the vicinity of the Purkinje neurons, may be an important underlying factor (Sivakumar et al., unpublished data). In parallel to the increased cytokine production, the expression of their receptors, TNF-R1 and IL-R1 on the Purkinje neurons was augmented by hypoxia (Sivakumar et al., unpublished data) implying that the AMCs play a pivotal role in the pathophysiological mechanism of hypoxic damage to the Purkinje neurons in the neonatal cerebellum through increased production of inflammatory cytokines.
Hypoxia induced damage in the developing retina
The retina, being an extension of the brain developmentally, is made up of basically similar cell types as the brain i.e. neurons and glial cells. The neurons are further classified into several types: the retinal ganglion cells (RGCs), amacrine cells, bipolar cells, horizontal cells and the photoreceptors. Three types of glial cells are found in the retina: the Müller cells, astrocytes and microglia. The pigment epithelium which forms the outermost layer of the retina is closely adherent to the photoreceptor layer. The multilayered neural retina consists of: the retinal pigment epithelium, photoreceptor layer, outer nuclear layer, outer plexiform layer, inner nuclear layer, inner plexiform layer, ganglion cell layer, nerve fibre layer and the inner limiting membrane. Here we will focus on the changes in AMCs and the RGCs in the hypoxic developing retina.
As in the brain, microglial cells in the developing retina also appear as round and amoeboidic displaying thick stout pseudopodial processes (Ling 1982). These cells, regarded as the counterpart of AMCs in the PWM, are distributed mainly in the nerve fiber and ganglion cell layers (Ling 1982) and are known to differentiate into ramified microglia in the late postnatal period (Santos et al. 2008). They have been described as similar to cells of the mononuclear phagocyte system (Chen et al. 2002). Although initially confined to the nerve fibre and the ganglion cell layer, they migrate to outer layers barring the outer nuclear layer in the second postnatal week (Ling 1982; Santos et al. 2008). Microglial cell numbers have been shown to increase in ischemia-induced retinopathy in the mouse retina (Davies et al. 2006).
Like the PWM, the immature retina is extremely susceptible to hypoxia-ischemia resulting in the development of retinopathy (Jacobson and Dutton 2000; Kaur et al. 2009b). As in the PWM, fetal and maternal factors mentioned above such as premature birth, placental insufficiency, pulmonary or cardiac dysfunction can result in hypoxia. Hypoxic damage in the developing retina has been characterized by retinal ganglion cell (RGC) death, swelling of Müller cells, changes in the retinal pigment epithelium and increased vascular leakage (Kaur et al. 2009b). Inflammation has been suggested as a major factor involved in the pathogenesis of hypoxia induced retinopathy, the AMCs playing a pivotal role in the process (Sivakumar et al. 2011).
Increased apoptosis of RGCs in the neonatal retina following a hypoxic exposure has been reported (Kaur et al. 2009b; Sivakumar et al. 2011). Involvement of AMCs in RGC death was evidenced by the enhanced expression and excess release of TNF-α and IL-1β by these cells in hypoxic conditions (Fig. 4) (Sivakumar et al. 2011). It was suggested that hypoxia may initiate inflammation by direct activation of AMCs and, hence, may play a pivotal role in the pathophysiological mechanism of hypoxic damage to the RGCs in the neonatal retina through increased production of proinflammatory cytokines. Increased production of TNF-α and IL-1β by the activated AMCs was accompanied by an up regulated expression of TNF-R1 and IL-R1 on the RGCs suggesting that binding of the cytokines to their respective receptors would be one of the major factors involved in RGC death.
It was further shown that the level of MCP-1, known to regulate the migration of microglia, macrophages and monocytes to the hypoxic and the inflammatory sites in the CNS (Deng et al. 2009), was increased by hypoxia and the AMCs were its main cellular source in the retina (Sivakumar et al. 2010). It was suggested that the increased expression of MCP-1 in the hypoxic neonatal retina had a similar function i.e. to attract macrophages and induce migration of microglia to the vicinity of RGCs thereby augmenting the inflammatory response. We have reported an increased expression of CCR2 that is known to control mononuclear phagocyte infiltration into the brain and regulate accumulation of microglia at sites of inflammation (El Khoury and Luster 2008), on the AMCs in the developing retina following hypoxic exposure (Sivakumar et al. 2011). It was suggested that the enhanced CCR2 expression may likely be associated with the active migration of AMCs from various sites to accumulate near the RGCs.
Conclusion
Increased production of inflammatory cytokines such as TNF-α and IL-1β by the AMCs in the developing PWM, cerebellum and retina appears to be involved in the apoptosis of the premyelinating oligodendrocytes, the RGCs and Purkinje neurons through upregulated expression of TNF-R1 and IL-R1 (Fig. 5). Further infiltration of macrophages/migration of AMCs may occur in the vicinity of the oligodendrocytes, Purkinje neurons and RGCs through augmented release of MCP-1 by the AMCs thus amplifying the inflammatory response.
In the PWM, besides inflammation, increased release of glutamate appears to damage the oligodendrocytes and the axons through mechanisms involving activation of AMPA and NMDA receptors on AMCs and release of inflammatory cytokines and NO. Iron induced increased ROS generation by the AMCs may also be involved in cell death in the hypoxic PWM through potentiating the release of inflammatory cytokines. The various mechanisms appear to be interlinked and culminate in heightened inflammation directly or indirectly through activation of AMCs. An understanding of these mechanisms would offer the prospect of development of a novel therapeutic strategy for manipulation of activated AMCs in hypoxic lesions of the developing brain and the retina.
Abbreviations
- AMCs:
-
Amoeboid microglial cells
- AMPA:
-
Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
- CNS:
-
Central nervous system
- CR3:
-
Complement type 3 receptors
- CSF-1:
-
Colony stimulating factor
- GluR2-4:
-
AMPA glutamate receptors
- IGF-1:
-
Insulin-like growth factor-1
- IGF-2:
-
Insulin-like growth factor-2
- IL-1 β:
-
Interleukin-1β
- IL-1R:
-
Interleukin 1 receptor
- iNOS:
-
Nitric oxide synthase
- MBP:
-
Myelin basic protein
- MCP-1:
-
Monocyte chemoattractant protein-1
- M-CSF:
-
Macrophage-colony stimulating factor
- MHC I:
-
Major histocompatibility class I antigens
- MHC II:
-
Major histocompatibility class II antigens
- NMDA:
-
N-methyl-D-aspartate
- NR1, NR2A-D:
-
NMDA receptor subunits
- NO:
-
Nitric oxide
- PWM:
-
Periventricular white matter
- PWMD:
-
Periventricular white matter damage
- RGC:
-
Retinal ganglion cell
- RGCs:
-
Retinal ganglion cells
- RNS:
-
Reactive nitrogen species
- ROS:
-
Reactive oxygen species
- TβRI and TβRII:
-
Transforming growth factor receptors I and II
- TGF-βl:
-
Transforming growth factor βl
- TNF-α:
-
Tumor necrosis factor –α
- TNF-R1, TNF-R2 :
-
TNF receptor 1 or 2
References
Aarum J, Sandberg K, Haeberlein SL, Persson MA (2003) Migration and differentiation of neural precursor cells can be directed by microglia. Proc Natl Acad Sci USA 100:15983–8
Abrahamson DR, Fearon DT (1983) Endocytosis of the C3b receptor of complement within coated pits in human polymorphonuclear leukocytes and monocytes. Lab Invest 48:162–168
Alliot F, Godin I, Pessac B (1999) Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Dev Brain Res 117:145–152
Aloisi F (2001) Immune function of microglia. Glia 36:165–179
Aloisi F, Ria F, Penna G, Adorini L (1998) Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 activation. J Immunol 160:4671–4680
Antony JM, Paquin A, Nutt SL, Kaplan DR, Miller FD (2011) Endogenous microglia regulate development of embryonic cortical precursor cells. J Neurosci Res 89:286–98
Barenberg P, Strahlendorf H, Strahlendorf J (2001) Hypoxia induces an excitotoxic-type of dark cell degeneration in cerebellar Purkinje neurons. Neurosci Res 40:245–254
Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245–313
Beller DI, Springer TA, Schreiber RD (1982) Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J Exp Med 156:1000–1009
Biran V, Heine VM, Verney C, Sheldon RA, Spadafora R, Vexler ZS, Rowitch DH, Ferriero DM (2011) Cerebellar abnormalities following hypoxia alone compared to hypoxic-ischemic forebrain injury in the developing rat brain. Neurobiol Dis 41:138–146
Brown GC (2007) Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem Soc Trans 35:1119–21
Cajal SR (1913) Contribucio’n al conocimiento de la neuroglia del cerebro humano. Trab Lab Invest Biol 11:255–345
Calvert JW, Zhang JH (2005) Pathophysiology of an hypoxic-ischemic insult during the perinatal period. Neurol Res 27:246–260
Carloni S, Mazzoni E, Cimino M, De Simoni MG, Perego C, Scopa C, Balduini W (2006) Simvastatin reduces caspase-3 activation and inflammatory markers induced by hypoxia-ischemia in the newborn rat. Neurobiol Dis 21:119–126
Chen L, Yang P, Kijlstra A (2002) Distribution, markers, and functions of retinal microglia. Ocul Immunol Inflamm 10:27–39
Cuadros MA, Martin C, Coltey P, Almendros A, Navascues J (1993) First appearance, distribution and origin of macrophages in the early development of the avian central nervous system. J Comp Neurol 330:113–129
Dammann O, Hagberg H, Leviton A (2001) Is periventricular leukomalacia an axonopathy as well as an oligopathy? Pediatr Res 49:453–457
Davies MH, Eubanks JP, Powers MR (2006) Microglia and macrophages are increased in response to ischemia-induced retinopathy in the mouse retina. Mol Vis 12:467–477
del Rio-Hortega P (1932) Microglia. In: Penfield W (ed) Cytology and cellular pathology of the nervous system, vol 2. Hoeber, New York, pp 483–534
Deng W, Rosenberg PA, Volpe JJ, Jensen FE (2003) Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors. Proc Natl Acad Sci USA 100:6801–6806
Deng YY, Lu J, Sivakumar V, Ling EA, Kaur C (2008) Amoeboid microglia in the periventricular white matter induces oligodendrocyte damage through expression of proinflammatory cytokines via MAP kinase signaling pathway in hypoxic neonatal rats. Brain Pathology 18:387–400
Deng YY, Lu J, Ling EA, Kaur C (2009) Monocyte chemoattractant protein-1 (MCP-1) produced via NF-B signaling pathway mediates migration of amoeboid microglia in the periventricular white matter in hypoxic neonatal rats. Glia 57:604–621
Deng YY, Lu J, Ling EA, Kaur C (2010) Microglia-derived macrophage colony stimulating factor promotes generation of proinflammatory cytokines by astrocytes in the periventricular white matter in the hypoxic neonatal brain. Brain Pathology 20:909–925
Dubois-Dalcq M, Murray K (2000) Why are growth factors important in oligodendrocyte physiology? Pathol Biol (Paris) 48:80–86
El Khoury J, Luster AD (2008) Mechanisms of microglia accumulation in Alzheimer’s disease: therapeutic implications. Trends Pharmacol Sci 29:626–632
Fantin A, Vieira JM, Gestri G, Denti L, Schwarz Q, Prykhozhij S, Peri F, Wilson SW, Ruhrberg C (2010) Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 116:829–40
Fern R, Moller T (2000) Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J Neurosci 20:34–42
Fiske BK, Brunjes PC (2000) Microglial activation in the developing rat olfactory bulb. Neuroscience 96:807–815
Folkerth RD (2006) Periventricular leukomalacia: overview and recent findings. Pediatr Dev Pathol 9:3–13
Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA, Volpe JJ, Jensen FE (2004) Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 24:4412–4420
Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizenmaier K, Eisel U (2002) Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 22:RC216
Gilman S (1992) Cerebellum and motor dysfunction. In: Asbury AK, McKhann GM, McDonald WI (eds) Diseases of the nervous system: Clinical neurobiology, 2nd edn. WB Saunder, Philadelphia, pp 319–341
Griot C, Vandevelde M, Richard A, Peterhans E, Stocker R (1990) Selective degeneration of oligodendrocytes mediated by reactive oxygen species. Free Radic Res Commun 11:181–193
Guan J, Bennet L, George S, Wu D, Waldvogel HJ, Gluckman PD, Faull RL, Crosier PS, Gunn AJ (2001) Insulin-like growth factor-1 reduces postischemic white matter injury in fetal sheep. J Cereb Blood Flow Metab 21:493–502
Guan J, Bennet L, Gluckman PD, Gunn AJ (2003) Insulin-like growth factor-1 and post-ischemic brain injury. Prog Neurobiol 70:443–462
Guillemin G, Boussin FD, Le Grand R, Croitoru J, Coffigny H, Dormont D (1996) Granulocyte macrophage colony stimulating factor stimulates in vitro proliferation of astrocytes derived from simian mature brains. Glia 16:71–80
Guo G, Bhat NR (2006) Hypoxia/reoxygenation differentially modulates NF-kappaB activation and iNOS expression in astrocytes and microglia. Antioxid Redox Signal 8:911–918
Hanisch UK (2002) Microglia as a source and target of cytokines. Glia 40:140–155
Hao C, Guilbert LJ, Fedoroff S (1990) Production of colony-stimulating factor-1 (CSF-1) by mouse astroglia in vitro. J Neurosci Res 27:314–23
Hao AJ, Dheen ST, Ling EA (2002) Expression of macrophage colony-stimulating factor and its receptor in microglia activation is linked to teratogen-induced neuronal damage. Neuroscience 112:889–900
Haynes RL, Baud O, Li J, Kinney HC, Volpe JJ, Folkerth DR (2005) Oxidative and nitrative injury in periventricular leukomalacia: a review. Brain Pathol 15:225–233
Huo Y, Rangarajan P, Ling EA, Dheen ST (2011) Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia. BMC Neurosci 12:49
Imamoto K, Leblond CP (1978) Radioautographic investigation of gliogenesis in the corpus callosum of young rats. II. Origin of microglial cells. J Comp Neurol 180:139–163
Inoue T, Saito H, Fukushima R, Inaba T, Lin MT, Fukatsu K, Muto T (1995) Growth hormone and insulinlike growth factor I enhance host defense in a murine sepsis model. Arch Surg 130:1115–1122
Jack CS, Arbour N, Blain M, Meier UC, Prat A, Antel JP (2007) Th1 polarization of CD4+ T cells by Toll-like receptor 3-activated human microglia. J Neuropathol Exp Neurol 66:848–59
Jacobson LK, Dutton GN (2000) Periventricular leukomalacia: an important cause of visual and ocular motility dysfunction in children. Surv Ophthalmol 45:1–13
Jiang X, Mu D, Sheldon RA, Glidden DV, Ferriero DM (2003) Neonatal hypoxia-ischemia differentially upregulates MAGUKs and associated proteins in PSD-93-deficient mouse brain. Stroke 34:2958–2963
Johnston MV (1997) Hypoxic and ischemic disorders of infants and children. Lecture for 38th meeting of Japanese Society of Child Neurology, Tokyo, Japan, July 1996. Brain Dev 19:235–239
Jonakait GM, Luskin MB, Wei R, Tian XF, Ni L (1996) Conditioned medium from activated microglia promotes cholinergic differentiation in the basal forebrain in vitro. Dev Biol 177:85–95
Jonakait GM, Wen Y, Wan Y, Ni L (2000) Macrophage cell-conditioned medium promotes cholinergic differentiation of undifferentiated progenitors and synergizes with nerve growth factor action in the developing basal forebrain. Exp Neurol 161:285–96
Kadhim H, Tabarki B, De Prez C, Rona AM, Sébire G (2002) Interleukin-2 in the pathogenesis of perinatal white matter damage. Neurology 58:1125–1128
Kadhim H, Khalifa M, Deltenre P, Casimir G, Sebire G (2006) Molecular mechanisms of cell death in periventricular leukomalacia. Neurology 67:293–299
Kaur C, Ling EA (1995) Transient expression of transferrin receptors and localisation of iron in amoeboid microglia in postnatal rats. J Anat 186:165–173
Kaur C, Ling EA (1999) Increased expression of transferrin receptors and iron in amoeboid microglial cells in postnatal rats following an exposure to hypoxia. Neurosci Lett 26:183–186
Kaur C, Ling EA (2009) Periventricular white matter damage in the hypoxic neonatal brain: role of microglial cells. Prog Neurobiol 87:264–280
Kaur C, Ling EA, Wong WC (1984) Cytochemical localisation of 5′-nucleotidase in amoeboid microglial cells in postnatal rats. J Anat 139:1–7
Kaur C, Ling EA, Wong WC (1985) Transformation of amoeboid microglial cells into microglia in the corpus callosum of the postnatal rat brain. An electron microscopical study. Arch Histol Jpn 48:17–25
Kaur C, Ling EA, Wong WC (1986) Labelling of amoeboid microglial cells in rats of various ages following an intravenous injection of horseradish peroxidase. Acta Anat 125:132–137
Kaur C, Hao AJ, Wu CH, Ling EA (2001) Origin of microglia. Microsc Res Tech 54:2–9
Kaur C, Too HF, Ling EA (2004) Phagocytosis of Escherichia coli by amoeboid microglial cells in the developing brain. Acta Neuropathol (Berl) 107:204–208
Kaur C, Sivakumar V, Ang LS, Sunderasan L (2006a) Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity. J Neurochem 98:1200–1216
Kaur C, Sivakumar V, Dheen ST, Ling EA (2006b) Insulin-like growth factor I and II expression and modulation in amoeboid microglial cells by lipopolysaccharide and retinoic acid. Neuroscience 138:1233–44
Kaur C, Sivakumar V, Yip GW, Ling EA (2009a) Expression of Syndecan-2 in the amoeboid microglial cells and its involvement in inflammation in the hypoxic developing brain. Glia 57:336–349
Kaur C, Sivakumar V, Foulds WS, Luu CD, Ling EA (2009b) Cellular and vascular changes in the retina of neonatal rats following an acute exposure to hypoxia. Investig Ophthalmol Vis Sci 50:5364–5374
Kubota Y, Takubo K, Shimizu T, Ohno H, Kishi K, Shibuya M, Saya H, Suda T (2009) M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J Exp Med 206:1089–102
Lavigne MC, Malech HL, Holland SM, Leto TL (2001) Genetic requirement of p47phox for superoxide production by murine microglia. FASEB J 15:285–287
Lee SC, Liu W, Roth P, Dickson DW, Berman JW, Brosnan CF (1993) Macrophage colony-stimulating factor in human fetal astrocytes and microglia. Differential regulation by cytokines and lipopolysaccharide, and modulation of class II MHC on microglia. J Immunol 150:594–604
Leong SK, Ling EA (1992) Amoeboid and ramified microglia: their interrelationship and response to brain injury. Glia 6:39–47
Li JJ, Lu J, Kaur C, Sivakumar V, Wu CY, Ling EA (2008) Effects of hypoxia on expression of transforming growth factor-beta1 and its receptors I and II in the amoeboid microglial cells and murine BV-2 cells. Neuroscience 156:662–72
Limperopoulos C, du Plessis AJ (2006) Disorders of cerebellar growth and development. Curr Opin Pediatr 18:621–627
Ling EA (1977) Light and electron microscopic demonstration of some lysosomal enzymes in the amoeboid microglia in neonatal rat brain. J Anat 123:637–648
Ling EA (1982) A light microscopic demonstration of amoeboid microglia and microglial cells in the retina of rats of various ages. Arch Histol Jpn 45:37–44
Ling EA, Tan CK (1974) Amoeboid microglial cells in the corpus callosum of neonatal rats. Arch Histol Jpn 36:265–280
Ling EA, Wong WC (1993) The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 7:9–18
Ling EA, Penney D, Leblond CP (1980) Use of carbon labelling to demonstrate the role of blood monocytes as precursors of the amoeboid cells present in the corpus callosum of postnatal rats. J Comp Neurol 193:631–657
Ling EA, Kaur C, Wong WC (1982) Light and electron microscopic demonstration of non-specific esterase in amoeboid microglial cells in the corpus callosum in postnatal rats: a cytochemical link to monocytes. J Anat 135:385–394
Ling EA, Kaur C, Yick TY, Wong WC (1990) Immunocytochemical localization of CR3 complement receptors with OX-42 in amoeboid microglia in postnatal rats. Anat Embryol 182:481–486
Ling EA, Kaur C, Wong WC (1991) Expression of major histocompatibility complex and leukocyte common antigens in amoeboid microglia in postnatal rats. J Anat 177:117–126
Logan A, Gonzalez AM, Hill DJ, Berry M, Gregson NA, Baird A (1994) Coordinated pattern of expression and localization of insulin-like growth factor-II (IGF-II) and IGF-binding protein-2 in the adult rat brain. Endocrinology 135:2255–2264
Lopez-Figueroa MO, Day HE, Lee S, Rivier C, Akil H, Watson SJ (2000) Temporal and anatomical distribution of nitric oxide synthase mRNA expression and nitric oxide production during central nervous system inflammation. Brain Res 852:239–246
Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, Rollins BJ (1998) Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187:601–608
Mallard EC, Rees S, Stringer M, Cock ML, Harding R (1998) Effects of chronic placental insufficiency on brain development in fetal sheep. Pediatr Res 43:262–270
Matute C, Alberdi E, Domercq M, Sanchez-Gomez MV, Perez-Samartin A, Rodriguez-Antiguedad A, Perez-Cerda F (2007) Excitotoxic damage to white matter. J Anat 210:693–702
McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP (1998) Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 4:291–7
McQuillen PS, Ferriero DM (2004) Selective vulnerability in the developing central nervous system. Pediatr Neurol 30:227–235
Meng SZ, Arai Y, Deguchi K, Takashima S (1997) Early detection of axonal and neuronal lesions in prenatal-onset periventricular leukomalacia. Brain Dev 19:480–484
Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE (1993) Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151:2132–2141
Murphy S, Simmons ML, Agullo L, Garcia A, Feinstein DL, Galea E, Reis DJ, Minc-Golomb D, Schwartz JP (1993) Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 16:323–8
Murphy GM Jr, Zhao F, Yang L, Cordell B (2000) Expression of macrophage colony-stimulating factor receptor is increased in the AβPP(V717F) transgenic mouse model of Alzheimer’s disease. Am J Pathol 157:895–904
Murugan M, Sivakumar V, Lu J, Ling EA, Kaur C (2011) Expression of N-methyl D-aspartate receptor subunits in amoeboid microglia mediates production of nitric oxide via NF-ĸB signalling pathway and oligodendrocyte cell death in hypoxic postnatal rats. Glia 59:521–539
Nakanishi H (2003) Microglial functions and proteases. Mol Neurobiol 27:163–176
Nakazawa T, Nakazawa C, Matsubara A, Noda K, Hisatomi T, She H et al (2006) Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci 26:12633–12641
Ness JK, Romanko MJ, Rothstein RP, Wood TL, Levison SW (2001) Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors. Dev Neurosci 23:203–208
Newman SL, Musson RA, Henson PM (1980) Development of functional complement receptors during in vitro maturation of human monocytes into macrophages. J Immunol 125:2236–2244
Nissl F (1899) Ueber einige Beziehungen zwischen Nervenzellerkrankungen und glio¨sen Erscheinungen bei verschiedenen Pschosen. Arch Psych 32:1–21
Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, Giustetto M, Alves Ferreira T, Guiducci E, Dumas L, Ragozzino D, Gross CT (2011) Synaptic pruning by microglia is necessary for normal brain development. Science 333:1456–1458
Perlman JM (2006) Intervention strategies for neonatal hypoxic-ischemic cerebral injury. Clin Ther 28:1353–1365
Perry VH, Hume DA, Gordon S (1985) Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience 15:313–26
Provis JM, Leech J, Diaz CM, Penfold PL, Stone J, Keshet E (1997) Development of the human retinal vasculature: cellular relations and VEGF expression. Exp Eye Res 65:555–68
Rankine EL, Hughes PM, Botham MS, Perry VH, Felton LM (2006) Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP-1-deficient mice prior to leucocyte recruitment. Eur J Neurosci 24:77–86
Rathnasamy G, Ling EA, Kaur C (2011) Iron and iron regulatory proteins in amoeboid microglial cells are linked to oligodendrocyte death in hypoxic neonatal rat periventricular white matter through production of proinflammatory cytokines and reactive oxygen/nitrogen species. J Neurosci 31:17982–95
Rymo SF, Gerhardt H, Wolfhagen Sand F, Lang R, Uv A, Betsholtz C (2011) A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures. PLoS One 6:e15846
Salter MG, Fern R (2005) NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438:1167–1171
Santos AM, Calvente R, Tassi M, Carrasco MC, Martín-Oliva D, Marín-Teva JL et al (2008) Embryonic and postnatal development of microglial cells in the mouse retina. J Comp Neurol 506:224–239
Sasmono RT, Oceandy D, Pollard JW, Tong W, Pavli P, Wainwright BJ, Ostrowski MC, Himes SR, Hume DA (2003) A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 101:1155–63
Sawada M, Suzumura A, Yamamoto H, Marunouchi T (1990) Activation and proliferation of the isolated microglia by colony stimulating factor-1 and possible involvement of protein kinase C. Brain Res 509:119–24
Sawada M, Itoh Y, Suzumura A, Marunouchi T (1993) Expression of cytokine receptors in cultured neuronal and glial cells. Neurosci Lett 160:131–4
Schafer DP, Lehrman EK, Kautzman AG, Barres B, Stevens B (2010) Synaptic pruning in the CNS: the role of microglia and the complement system. Soc Neurosci Abstr 36:554.5
Shafit-Zagardo B, Sharma N, Berman JW, Bornstein MB, Brosnan CF (1993) CSF-1 expression is upregulated in astrocyte cultures by IL-1 and TNF and affects microglial proliferation and morphology in organotypic cultures. Int J Dev Neurosci 11:189–98
Sivakumar V, Ling EA, Lu J, Kaur C (2010) Role of glutamate and its receptors and insulin-like growth factors in hypoxia induced periventricular white matter injury. Glia 58:507–523
Sivakumar V, Foulds WS, Luu CD, Ling EA, Kaur C (2011) Retinal ganglion cell death is induced by microglia derived proinflammatory cytokines in the hypoxic neonatal retina. J Path 224:245–260
Skoff RP, Bessert DA, Barks JD, Song D, Cerghet M, Silverstein FS (2001) Hypoxic-ischemic injury results in acute disruption of myelin gene expression and death of oligodendroglial precursors in neonatal mice. Int J Dev Neurosci 19:197–208
Streit WJ (2001) Microglia and macrophages in the developing CNS. Neurotoxicology 22:619–624
Suzumura A, Sawada M, Yamamoto H, Marunouchi T (1990) Effects of colony stimulating factors on isolated microglia in vitro. J Neuroimmunol 30:111–20
Takashima S, Iida K, Deguchi K (1995) Periventricular leukomalacia, glial development and myelination. Early Hum Dev 43:177–184
Takeuchi A, Miyaishi O, Kiuchi K, Isobe K (2001) Macrophage colony-stimulating factor is expressed in neuron and microglia after focal brain injury. J Neurosci Res 65:38–44
Tekkök SB, Goldberg MP (2001) Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 21:4237–4248
Tkachuk M, Gisler RH (1997) The promoter of macrophage colony-stimulating factor receptor is active in astrocytes. Neurosci Lett 225:121–125
Tremblay ME, Lowery RL, Majewska AK (2010) Microglial interactions with synapses are modulated by visual experience. PLoS Biol 8:e1000527
van der Goes A, Brouwer J, Hoekstra K, Roos D, van den Berg TK, Dijkstra CD (1998) Reactive oxygen species are required for the phagocytosis of myelin by macrophages. J Neuroimmunol 92(1–2):67–75
Vela JM, Molina-Holgado E, Arévalo-Martin A, Almazán G, Guaza C (2002) Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol Cell Neurosci 20:489–502
Volpe JJ (2003) Cerebral white matter injury of the premature infant—more common than you think. Pediatrics 112:176–180
Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J (2009) Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 29:3974–3980
Walter HJ, Berry M, Hill DJ, Cwyfan-Hughes S, Holly JM, Logan A (1999) Distinct sites of insulin-like growth factor (IGF)-II expression and localization in lesioned rat brain: possible roles of IGF binding proteins (IGFBPs) in the mediation of IGF-II activity. Endocrinology 140:520–532
Wu CH, Wen CY, Shieh JY, Ling EA (1994) Down-regulation of membrane glycoprotein in amoeboid microglia transforming into ramified microglia in postnatal rat brain. J Neurocytol 23:258–269
Wu CY, Kaur C, Sivakumar V, Lu J, Ling EA (2009) Kv1.1 expression in microglia regulates production and release of proinflammatory cytokines, endothelins and nitric oxide. Neuroscience 158:1500–1508
Xu J, Ling EA (1994a) Upregulation and induction of surface antigens with special reference to MHC class II expression in microglia in postnatal rat brain following intravenous or intraperitoneal injections of lipopolysaccharide. J Anat 184:285–296
Xu J, Ling EA (1994b) Studies of the ultrastructure and permeability of the blood–brain barrier in the developing corpus callosum in postnatal rat brain using electron dense tracers. J Anat 184:227–237
Xu J, Kaur C, Ling EA (1993) Variation with age in the labelling of amoeboid microglial cells in rats following intraperitoneal or intravenous injection of a fluorescent dye. J Anat 182:55–63
Yan YP, Sailor KA, Lang BT, Park SW, Vemuganti R, Dempsey RJ (2007) Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia. J Cereb Blood Flow Metab 27:1213–1224
Yoshioka A, Hardy M, Younkin DP, Grinspan JB, Stern JL, Pleasure D (1995) Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J Neurochem 64:2442–8
You Y, Kaur C (2000) Expression of induced nitric oxide synthase in amoeboid microglia in postnatal rats following an exposure to hypoxia. Neurosci Lett 279:101–104
Zhu P, Hata R, Cao F, Gu F, Hanakawa Y, Hashimoto K, Sakanaka M (2008) Ramified microglial cells promote astrogliogenesis and maintenance of neural stem cells through activation of Stat3 function. FASEB J 22:3866–77
Acknowledgements
This study was supported by a research grant (R181-000-120-213) from National Medical Research Council of Singapore. We thank Dr. Viswanathan Sivakumar for providing the technical assistance. There is no conflict of interest among the authors.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Charanjit Kaur and Eng-Ang Ling contributed equally to this manuscript.
Rights and permissions
About this article
Cite this article
Kaur, C., Rathnasamy, G. & Ling, EA. Roles of Activated Microglia in Hypoxia Induced Neuroinflammation in the Developing Brain and the Retina. J Neuroimmune Pharmacol 8, 66–78 (2013). https://doi.org/10.1007/s11481-012-9347-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-012-9347-2